According to the latest research study, the global epilepsy treatment devices market was valued at approximately USD 526.8 Million in 2023 and is expected to reach a value of around USD 787.3 Million ...

The effect of levetiracetam on high-frequency oscillations in patients with AD and epilepsy shows its potential as a biomarker for disease detection.

JUST before her first birthday, Camden Haven’s Josie Neilson experienced ‘Status epilepticus’, a condition involving ...